V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215570 | 20130472 | 1.55 | null | null | 2019-03-11 | 2019-03-11 | Cetuximab + FOLFIRI cycle1 | 02 | null | TRIAL | 100498300 |
| 20215572 | 20130473 | 0 | 69.3 | Palliative (P) | 2018-11-23 | 2019-05-09 | EOX | N | N | TRIAL | 100130273 |
| 20215573 | 20130474 | 1.72 | 64.4 | Palliative (P) | 2018-04-06 | 2018-05-06 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100865769 |
| 20215574 | 20130475 | null | 82 | null | 2016-10-05 | 2016-10-27 | IRINOTECAN + MDG + PANITUMUMAB | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101681001 |
| 20215575 | 20130476 | 1.78 | 82.6 | null | 2017-08-27 | 2017-08-27 | IRINOTECAN + MDG + PANITUMUMAB | 2 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101418065 |
| 20215576 | 20130477 | null | 53.6 | Palliative (P) | 2018-09-06 | 2018-10-01 | GO2 TRIAL | N | N | TRIAL | 100647058 |
| 20215577 | 20130478 | 1.73 | 85.4 | Curative (C) | 2019-06-21 | 2019-07-05 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101361849 |
| 20215578 | 20130479 | 1.81 | 55.8 | Palliative (P) | 2019-10-11 | 2019-10-11 | Sorafenib | null | N | SORAFENIB | 101144353 |
| 20215579 | 20130480 | 1.7 | 80 | 03 | 2016-11-13 | 2016-11-28 | EOX | 99 | N | CAPECITABINE + RT | 100649407 |
| 20215581 | 20130481 | 1.63 | 84 | Palliative (P) | 2018-12-08 | 2018-12-21 | EOX | 02 | N | EOX | 101369155 |
| 20215585 | 20130482 | 1.52 | 51.4 | Palliative (P) | 2018-04-16 | 2018-05-01 | Sorafenib | 02 | N | SORAFENIB | 100805407 |
| 20215586 | 20130483 | 1.69 | 74.8 | Palliative (P) | 2019-03-21 | 2019-03-27 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 100755239 |
| 20215589 | 20130484 | 1.57 | 58 | Adjuvant (A) | null | 2016-10-26 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100252894 |
| 20215591 | 20130485 | 1.49 | 72.95 | Palliative (P) | 2018-08-02 | 2018-08-03 | Sorafenib | 99 | N | SORAFENIB | 101724015 |
| 20215592 | 20130486 | 1.86 | 107.4 | null | 2019-10-09 | 2020-01-31 | EOX | N | null | CETUXIMAB + IRINOTECAN + MDG | 100913013 |
| 20215594 | 20130487 | 1.63 | 68 | Palliative (P) | 2017-09-23 | 2018-03-17 | Capecitabine 5days + RT | N | N | CAPECITABINE + RT | 101626679 |
| 20215595 | 20130488 | 1.64 | 96 | Palliative (P) | 2019-12-27 | 2019-12-31 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100853330 |
| 20215596 | 20130489 | 1.85 | 59.4 | Palliative (P) | 2018-04-04 | 2018-04-05 | Sorafenib | N | N | SORAFENIB | 101054845 |
| 20215597 | 20130490 | 1.79 | 55 | Palliative (P) | 2016-10-28 | 2016-10-28 | IRINOTECAN + MDG + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101181409 |
| 20215598 | 20130491 | 1.6 | 87.6 | null | 2019-09-17 | 2019-10-15 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100725668 |
| 20215603 | 20130492 | 1.5 | 56 | null | 2018-04-11 | 2018-04-30 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101105477 |
| 20215604 | 20130493 | 1.83 | 54 | Palliative (P) | null | 2019-01-04 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101054888 |
| 20215605 | 20130494 | 1.57 | 0 | Palliative (P) | 2020-02-09 | 2020-02-09 | Trial Unspecified | 1 | N | SORAFENIB | 100775031 |
| 20215606 | 20130495 | 1.63 | 64 | Palliative (P) | 2016-04-06 | 2016-05-16 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101215236 |
| 20215607 | 20130496 | 1.8 | 91 | Palliative (P) | 2017-05-03 | 2017-10-17 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101274518 |
| 20215608 | 20130497 | 1.71 | 75 | null | 2017-02-14 | 2017-04-20 | CETUXIMAB + IRINOTECAN + MDG | 99 | Y | CETUXIMAB + IRINOTECAN + MDG | 101485126 |
| 20215609 | 20130498 | 1.74 | 72.7 | Neo-adjuvant (N) | 2019-07-17 | 2019-07-31 | Capecitabine 35days + RT | 2 | N | CAPECITABINE + RT | 101630740 |
| 20215612 | 20130499 | 0 | 69.9 | Adjuvant (A) | 2019-04-25 | 2019-05-10 | Sorafenib | 02 | Y | SORAFENIB | 100671339 |
| 20215618 | 20130500 | 1.76 | 54.8 | 03 | 2017-02-01 | 2017-02-01 | EOX | 2 | N | OXALIPLATIN + RALTITREXED | 101125870 |
| 20215620 | 20130501 | 1.59 | 37.9 | Palliative (P) | 2017-10-06 | 2017-10-31 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100499947 |
| 20215623 | 20130502 | 1.81 | 106.8 | Palliative (P) | 2017-08-12 | 2018-10-11 | EOX | null | Y | TRIAL | 100882737 |
| 20215626 | 20130503 | 1.85 | 55.7 | Neo-adjuvant (N) | 2021-11-29 | 2021-12-07 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101722310 |
| 20215627 | 20130504 | 1.88 | 95.4 | Adjuvant (A) | 2021-12-05 | 2022-01-07 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100779304 |
| 20215630 | 20130505 | 1.65 | 51 | Adjuvant (A) | 2018-08-19 | 2018-09-29 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 1 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100242920 |
| 20215632 | 20130506 | 1.72 | 54.8 | Palliative (P) | 2018-07-31 | 2018-08-04 | Sorafenib | 1 | Y | SORAFENIB | 100812793 |
| 20215633 | 20130507 | 1.77 | 84 | null | 2017-10-29 | 2017-10-29 | EOX | 99 | null | CETUXIMAB + IRINOTECAN + MDG | 100805043 |
| 20215634 | 20130508 | 1.84 | 99.9 | null | 2016-08-17 | 2016-08-22 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 100782162 |
| 20215638 | 20130509 | 1.78 | 77.5 | null | 2022-01-02 | 2022-01-02 | IRINOTECAN + MDG + PANITUMUMAB | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100759091 |
| 20215639 | 20130510 | 1.65 | 79.4 | Palliative (P) | 2020-06-29 | 2020-07-02 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101435601 |
| 20215640 | 20130511 | 1.71 | 102.7 | Palliative (P) | 2019-05-28 | 2019-06-11 | EOX | 02 | N | EOX | 101635580 |
| 20215641 | 20130512 | 1.83 | 69.9 | Palliative (P) | 2019-05-14 | 2019-05-14 | GO2 TRIAL | 99 | N | TRIAL | 101284793 |
| 20215642 | 20130513 | 1.63 | 80 | null | 2017-10-24 | 2017-11-29 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101129038 |
| 20215643 | 20130514 | 1.61 | 73 | Palliative (P) | 2017-08-13 | 2017-08-13 | Trial Unspecified | N | N | TRIAL | 100674154 |
| 20215646 | 20130515 | 1.69 | 99.5 | null | 2021-08-02 | 2021-10-09 | Oxaliplatin + Raltitrexed | 2 | N | OXALIPLATIN + RALTITREXED | 100150976 |
| 20215647 | 20130516 | 1.57 | 84.7 | Curative (C) | 2020-03-16 | 2020-03-23 | EOX | 02 | N | EOX | 100138089 |
| 20215648 | 20130517 | 1.7 | 59.9 | Palliative (P) | 2020-01-10 | 2020-01-23 | EOX | N | N | TRIAL | 101541452 |
| 20215652 | 20130518 | 1.62 | 90 | Adjuvant (A) | 2016-07-16 | 2016-07-16 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100014194 |
| 20215653 | 20130519 | 1.57 | 86.8 | null | 2016-06-16 | 2016-06-20 | CAPECITABINE + RT | 2 | null | CAPECITABINE + RT | 100628543 |
| 20215654 | 20130520 | 1.67 | 103.65 | Disease modification (D) | 2019-08-23 | 2019-09-20 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 100957230 |
| 20215655 | 20130521 | 1.6 | 74.7 | Neo-adjuvant (N) | 2020-12-18 | 2021-01-02 | Trial Unspecified | 02 | null | EOX | 100459339 |